NASDAQ: AIDX
20/20 Biolabs Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their AIDX stock forecasts and price targets.

Forecast return on equity

Is AIDX forecast to generate an efficient return?

Company
-1,097.49%
Industry
14.71%
Market
148.08%
AIDX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AIDX forecast to generate an efficient return on assets?

Company
-133.67%
Industry
11.53%
AIDX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AIDX earnings per share forecast

What is AIDX's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.53
Avg 2 year Forecast
-$0.39
Avg 3 year Forecast
-$0.48

AIDX revenue forecast

What is AIDX's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$2.7M+33.44%
Avg 2 year Forecast
$5.9M+193.99%
Avg 3 year Forecast
$9.1M+352.8%
AIDX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AIDX revenue growth forecast

How is AIDX forecast to perform vs Medical Devices companies and vs the US market?

Company
71.29%
Industry
5.71%
Market
12.17%
AIDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AIDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AIDX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
AIDX$0.16N/AN/A
IVF$1.76N/AN/A
TNON$0.90N/AN/A
BJDX$1.70N/AN/A
NUWE$3.41N/AN/A

20/20 Biolabs Stock Forecast FAQ

What is AIDX's earnings growth forecast for 2026-2028?

(NASDAQ: AIDX) 20/20 Biolabs's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 30.08%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 72.25%.

20/20 Biolabs's earnings in 2026 is -$7,684,628.On average, 3 Wall Street analysts forecast AIDX's earnings for 2026 to be -$7,421,446, with the lowest AIDX earnings forecast at -$7,130,409, and the highest AIDX earnings forecast at -$7,639,724. On average, 3 Wall Street analysts forecast AIDX's earnings for 2027 to be -$5,423,364, with the lowest AIDX earnings forecast at -$5,210,683, and the highest AIDX earnings forecast at -$5,582,875.

In 2028, AIDX is forecast to generate -$6,707,845 in earnings, with the lowest earnings forecast at -$6,444,793 and the highest earnings forecast at -$6,905,135.

If you're new to stock investing, here's how to buy 20/20 Biolabs stock.

What is AIDX's revenue growth forecast for 2026-2028?

(NASDAQ: AIDX) 20/20 Biolabs's forecast annual revenue growth rate of 71.29% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.71%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.17%.

20/20 Biolabs's revenue in 2026 is $2,002,436.On average, 3 Wall Street analysts forecast AIDX's revenue for 2026 to be $37,387,073, with the lowest AIDX revenue forecast at $35,931,887, and the highest AIDX revenue forecast at $38,492,454. On average, 3 Wall Street analysts forecast AIDX's revenue for 2027 to be $82,371,893, with the lowest AIDX revenue forecast at $79,153,694, and the highest AIDX revenue forecast at $84,806,530.

In 2028, AIDX is forecast to generate $126,866,987 in revenue, with the lowest revenue forecast at $121,885,775 and the highest revenue forecast at $130,588,904.

What is AIDX's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: AIDX) forecast ROA is -133.67%, which is lower than the forecast US Medical Devices industry average of 11.53%.

What is AIDX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: AIDX) 20/20 Biolabs's current Earnings Per Share (EPS) is -$0.92. On average, analysts forecast that AIDX's EPS will be -$0.53 for 2026, with the lowest EPS forecast at -$0.51, and the highest EPS forecast at -$0.55. On average, analysts forecast that AIDX's EPS will be -$0.39 for 2027, with the lowest EPS forecast at -$0.37, and the highest EPS forecast at -$0.40. In 2028, AIDX's EPS is forecast to hit -$0.48 (min: -$0.46, max: -$0.49).

What is AIDX's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: AIDX) forecast ROE is -1,097.49%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.